Pathogen Box research | Medicines for Malaria Venture
Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery | Antimicrobial Agents and Chemotherapy
Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discovery - MedChemComm (RSC Publishing)
Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activity | Scientific Reports
Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery | Antimicrobial Agents and Chemotherapy
Parcel Packaging as a Vector of Pathogen Transmission - Berkshire Corporation
Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages | Antimicrobial Agents and Chemotherapy
Infection Control & Clean-up Kit, poly box | NorMed
Pathogens | Free Full-Text | Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors
Pathogen Reduction Box 3.0 | HEPACART™
Identification of Small Molecule Inhibitors of the Pathogen Box against Vibrio cholerae | Microbiology Spectrum
An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery - ScienceDirect
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis | PLOS ONE